WO2010024586A3 - Nouveau composé dérivé de benzamide et son procédé de fabrication - Google Patents

Nouveau composé dérivé de benzamide et son procédé de fabrication Download PDF

Info

Publication number
WO2010024586A3
WO2010024586A3 PCT/KR2009/004754 KR2009004754W WO2010024586A3 WO 2010024586 A3 WO2010024586 A3 WO 2010024586A3 KR 2009004754 W KR2009004754 W KR 2009004754W WO 2010024586 A3 WO2010024586 A3 WO 2010024586A3
Authority
WO
WIPO (PCT)
Prior art keywords
compound
derivative compound
producing same
benzamide derivative
novel benzamide
Prior art date
Application number
PCT/KR2009/004754
Other languages
English (en)
Korean (ko)
Other versions
WO2010024586A2 (fr
Inventor
유무희
이재걸
임원빈
최성학
박정상
최선호
손태경
성현정
손주희
조강훈
Original Assignee
동아제약주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 동아제약주식회사 filed Critical 동아제약주식회사
Publication of WO2010024586A2 publication Critical patent/WO2010024586A2/fr
Publication of WO2010024586A3 publication Critical patent/WO2010024586A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La présente invention concerne un composé de la formule chimique (I), des isomères de celui-ci ou des sels pharmaceutiquement acceptables de ce composé et ses isomères; un procédé de production du composé et de ses isomères et une composition pharmaceutique qui est efficace sur des récepteurs 5-HT4 et qui contient le composé ou un isomère de celui-ci comme principe actif.
PCT/KR2009/004754 2008-09-01 2009-08-26 Nouveau composé dérivé de benzamide et son procédé de fabrication WO2010024586A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020080085718A KR20100026641A (ko) 2008-09-01 2008-09-01 신규한 벤즈아미드 유도체 화합물 및 그의 제조방법
KR10-2008-0085718 2008-09-01

Publications (2)

Publication Number Publication Date
WO2010024586A2 WO2010024586A2 (fr) 2010-03-04
WO2010024586A3 true WO2010024586A3 (fr) 2010-06-24

Family

ID=41722109

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2009/004754 WO2010024586A2 (fr) 2008-09-01 2009-08-26 Nouveau composé dérivé de benzamide et son procédé de fabrication

Country Status (2)

Country Link
KR (1) KR20100026641A (fr)
WO (1) WO2010024586A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2942285T3 (es) 2016-10-31 2023-05-31 Biocryst Pharm Inc Profármacos de inhibidores de la calicreína
KR20230005893A (ko) * 2020-05-04 2023-01-10 다케다 야쿠힌 고교 가부시키가이샤 내강 작용 n-(피페리딘-4-일)벤즈아미드 유도체

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998016511A1 (fr) * 1996-10-15 1998-04-23 Janssen Pharmaceutica N.V. Synthese de cisapride
US5783702A (en) * 1994-10-07 1998-07-21 Torcan Chemical Ltd. Preparation of cisapride
WO1999002496A1 (fr) * 1997-07-11 1999-01-21 Janssen Pharmaceutica N.V. (+)-norcisapride utiles pour traiter les troubles a mediation 5-ht3 et 5-ht4
WO2001093849A2 (fr) * 2000-06-07 2001-12-13 Aryx Therapeutics Materiaux et methodes permettant de traiter le reflux gastro-oesophagien
WO2002036113A1 (fr) * 2000-11-01 2002-05-10 Respiratorius Ab Composition comprenant des agonistes (5ht-4) et des antagonistes (5ht-2, 5ht-3) recepteurs de la serotonine

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783702A (en) * 1994-10-07 1998-07-21 Torcan Chemical Ltd. Preparation of cisapride
WO1998016511A1 (fr) * 1996-10-15 1998-04-23 Janssen Pharmaceutica N.V. Synthese de cisapride
WO1999002496A1 (fr) * 1997-07-11 1999-01-21 Janssen Pharmaceutica N.V. (+)-norcisapride utiles pour traiter les troubles a mediation 5-ht3 et 5-ht4
WO2001093849A2 (fr) * 2000-06-07 2001-12-13 Aryx Therapeutics Materiaux et methodes permettant de traiter le reflux gastro-oesophagien
WO2002036113A1 (fr) * 2000-11-01 2002-05-10 Respiratorius Ab Composition comprenant des agonistes (5ht-4) et des antagonistes (5ht-2, 5ht-3) recepteurs de la serotonine

Also Published As

Publication number Publication date
WO2010024586A2 (fr) 2010-03-04
KR20100026641A (ko) 2010-03-10

Similar Documents

Publication Publication Date Title
NO20080865L (no) Spirokromanonderivater som acetyl-koenzym-A-karboksylase(ACC)inhibitorer
NO20072978L (no) Nye betuinderivater, preparat derav og anvendelse derav
WO2010136474A3 (fr) Dérivés aminobutyriques substitués en tant qu'inhibiteurs de néprilysine
ATE540932T1 (de) Hydantoin-derivate als antibakterielle wirkstoffe
WO2008005368A3 (fr) Pipérazines en tant qu'antagonistes de p2x7
NO20092762L (no) 2-aza-bicyklo[3.1.0]heksanderivater
TN2012000125A1 (en) Substituted carbamoylmethylamino acetic acid derivatives as novel nep inhibitors
WO2010105179A3 (fr) Inhibiteurs de bêta-sécrétase
WO2010114275A3 (fr) Composition pour inhiber un érythème provoqué par un rayonnement ultraviolet et contenant un dipeptide en tant que principe actif
WO2009065919A3 (fr) Nouveaux composés
MX347706B (es) Derivados de triazol y su uso para trastornos neurologicos.
WO2007109578A3 (fr) Gamma lactames substitues en tant qu'agents therapeutiques
WO2009065922A3 (fr) Nouveaux composés
WO2007017728A3 (fr) Nouveaux composes heterocycliques
MX2009010302A (es) Derivados de indol que tienen actividad inhibidora de cpla2 y aplicaciones y metodos de produccion.
WO2010024930A3 (fr) Analogues de cortistatine et leurs synthèses
WO2008052379A3 (fr) Composés organiques
WO2011025982A3 (fr) Composés tétracycline
WO2010011811A3 (fr) Composés de 3-(phénoxyphénylméthyl)pyrrolidine
WO2012140596A8 (fr) Dérivés de glycoside et leurs utilisations
MX2010003849A (es) Antagonistas de cgrp.
MX2013001965A (es) Compuestos disustituidos de tetrahidrofuranilo como antagonistas de receptor de bradiquinina b1
WO2013036015A3 (fr) Dérivé d'azétidine et composition antidépressive en contenant
WO2011008666A3 (fr) Composés 3-phénoxyméthylpyrrolidines
UA107702C2 (en) Novel benzamide derivatives

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09810191

Country of ref document: EP

Kind code of ref document: A2

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09810191

Country of ref document: EP

Kind code of ref document: A2